GH Research PLC announced its participation in a Mini-Panel Session at the 64th ACNP annual meeting from January 12-15, 2026, in Nassau, Bahamas, discussing clinical trial results. The presentations will cover GH001-TRD-201, GH001-PPD-203, and GH001-BD-202, with information provided as of January 15, 2026.